A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme

Uracil–DNA glycosylases are enzymes that excise uracil bases appearing in DNA as a result of cytosine deamination or accidental dUMP incorporation from the dUTP pool. The activity of Family 1 uracil–DNA glycosylase (UNG) activity limits the efficiency of antimetabolite drugs and is essential for vir...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Inga R. Grin, Grigory V. Mechetin, Rustem D. Kasymov, Evgeniia A. Diatlova, Anna V. Yudkina, Sergei N. Shchelkunov, Irina P. Gileva, Alexandra A. Denisova, Grigoriy A. Stepanov, Ghermes G. Chilov, Dmitry O. Zharkov
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/4eccb9b2add64a62a6373d3ddfe88e90
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4eccb9b2add64a62a6373d3ddfe88e90
record_format dspace
spelling oai:doaj.org-article:4eccb9b2add64a62a6373d3ddfe88e902021-11-11T18:37:43ZA New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme10.3390/molecules262166681420-3049https://doaj.org/article/4eccb9b2add64a62a6373d3ddfe88e902021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6668https://doaj.org/toc/1420-3049Uracil–DNA glycosylases are enzymes that excise uracil bases appearing in DNA as a result of cytosine deamination or accidental dUMP incorporation from the dUTP pool. The activity of Family 1 uracil–DNA glycosylase (UNG) activity limits the efficiency of antimetabolite drugs and is essential for virulence in some bacterial and viral infections. Thus, UNG is regarded as a promising target for antitumor, antiviral, antibacterial, and antiprotozoal drugs. Most UNG inhibitors presently developed are based on the uracil base linked to various substituents, yet new pharmacophores are wanted to target a wide range of UNGs. We have conducted virtual screening of a 1,027,767-ligand library and biochemically screened the best hits for the inhibitory activity against human and vaccinia virus UNG enzymes. Although even the best inhibitors had IC<sub>50</sub> ≥ 100 μM, they were highly enriched in a common fragment, tetrahydro-2,4,6-trioxopyrimidinylidene (PyO3). In silico, PyO3 preferably docked into the enzyme’s active site, and in kinetic experiments, the inhibition was better consistent with the competitive mechanism. The toxicity of two best inhibitors for human cells was independent of the presence of methotrexate, which is consistent with the hypothesis that dUMP in genomic DNA is less toxic for the cell than strand breaks arising from the massive removal of uracil. We conclude that PyO3 may be a novel pharmacophore with the potential for development into UNG-targeting agents.Inga R. GrinGrigory V. MechetinRustem D. KasymovEvgeniia A. DiatlovaAnna V. YudkinaSergei N. ShchelkunovIrina P. GilevaAlexandra A. DenisovaGrigoriy A. StepanovGhermes G. ChilovDmitry O. ZharkovMDPI AGarticleDNA repairuracil–DNA glycosylaseinhibitorsvirtual screeningpyrimidinesOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6668, p 6668 (2021)
institution DOAJ
collection DOAJ
language EN
topic DNA repair
uracil–DNA glycosylase
inhibitors
virtual screening
pyrimidines
Organic chemistry
QD241-441
spellingShingle DNA repair
uracil–DNA glycosylase
inhibitors
virtual screening
pyrimidines
Organic chemistry
QD241-441
Inga R. Grin
Grigory V. Mechetin
Rustem D. Kasymov
Evgeniia A. Diatlova
Anna V. Yudkina
Sergei N. Shchelkunov
Irina P. Gileva
Alexandra A. Denisova
Grigoriy A. Stepanov
Ghermes G. Chilov
Dmitry O. Zharkov
A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
description Uracil–DNA glycosylases are enzymes that excise uracil bases appearing in DNA as a result of cytosine deamination or accidental dUMP incorporation from the dUTP pool. The activity of Family 1 uracil–DNA glycosylase (UNG) activity limits the efficiency of antimetabolite drugs and is essential for virulence in some bacterial and viral infections. Thus, UNG is regarded as a promising target for antitumor, antiviral, antibacterial, and antiprotozoal drugs. Most UNG inhibitors presently developed are based on the uracil base linked to various substituents, yet new pharmacophores are wanted to target a wide range of UNGs. We have conducted virtual screening of a 1,027,767-ligand library and biochemically screened the best hits for the inhibitory activity against human and vaccinia virus UNG enzymes. Although even the best inhibitors had IC<sub>50</sub> ≥ 100 μM, they were highly enriched in a common fragment, tetrahydro-2,4,6-trioxopyrimidinylidene (PyO3). In silico, PyO3 preferably docked into the enzyme’s active site, and in kinetic experiments, the inhibition was better consistent with the competitive mechanism. The toxicity of two best inhibitors for human cells was independent of the presence of methotrexate, which is consistent with the hypothesis that dUMP in genomic DNA is less toxic for the cell than strand breaks arising from the massive removal of uracil. We conclude that PyO3 may be a novel pharmacophore with the potential for development into UNG-targeting agents.
format article
author Inga R. Grin
Grigory V. Mechetin
Rustem D. Kasymov
Evgeniia A. Diatlova
Anna V. Yudkina
Sergei N. Shchelkunov
Irina P. Gileva
Alexandra A. Denisova
Grigoriy A. Stepanov
Ghermes G. Chilov
Dmitry O. Zharkov
author_facet Inga R. Grin
Grigory V. Mechetin
Rustem D. Kasymov
Evgeniia A. Diatlova
Anna V. Yudkina
Sergei N. Shchelkunov
Irina P. Gileva
Alexandra A. Denisova
Grigoriy A. Stepanov
Ghermes G. Chilov
Dmitry O. Zharkov
author_sort Inga R. Grin
title A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
title_short A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
title_full A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
title_fullStr A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
title_full_unstemmed A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
title_sort new class of uracil–dna glycosylase inhibitors active against human and vaccinia virus enzyme
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4eccb9b2add64a62a6373d3ddfe88e90
work_keys_str_mv AT ingargrin anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT grigoryvmechetin anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT rustemdkasymov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT evgeniiaadiatlova anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT annavyudkina anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT sergeinshchelkunov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT irinapgileva anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT alexandraadenisova anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT grigoriyastepanov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT ghermesgchilov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT dmitryozharkov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT ingargrin newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT grigoryvmechetin newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT rustemdkasymov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT evgeniiaadiatlova newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT annavyudkina newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT sergeinshchelkunov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT irinapgileva newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT alexandraadenisova newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT grigoriyastepanov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT ghermesgchilov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
AT dmitryozharkov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme
_version_ 1718431760949182464